Novavax

Thursday, June 9, 2022 Edit

NASDAQNASDAQNVAX Q1 2022 Results Earnings Conference Call May 09 2022 0430 PM ET Company Participants Silvia Taylor - SVP Global Corporate Affairs IR Stan Erck -. Download COVID-19 vaccination After your Nuvaxovid Novavax vaccine as Word - 981 KB 3 pages We aim to provide documents in an accessible format.

Pin On Menafn

The FDA committee will review Novavaxs vaccine for adults ages 18 and over on June 7.

. Bank of America Securities analyst Alec Stranahan. The company reported quarterly earnings of 256 per share which came in below the. Previewing the earnings KeyBanc Capital Markets analyst Leo Mariani said in late April he expects Plug Powers revenue to miss the consensus by 46 and margin to contract slightly from a.

Novavax reported first-quarter revenue of 704 million which came in below the 8452 million estimate. The FDA has selected three possible dates June 8 21 and 22 to discuss Moderna and Pfizers shots for. We would like to show you a description here but the site wont allow us.

If youre having problems using a document with your accessibility tools please contact us for help. At Yahoo Finance you get free stock quotes up-to-date news portfolio management resources international market data social interaction and mortgage rates that help you manage your financial life. Novavax is not currently registered for use as a booster dose.

Two months later there is still no sign of a decision from regulators. Novavax stock was dropping Friday after receiving a Sell-equivalent rating the first since December 2020 and the only one from Wall Street. Novavax filed for emergency use for its COVID-19 vaccine with the FDA Jan.

Immunocompromised individuals who have received 3 primary doses of a COVID-19 vaccine are also recommended to have a booster dose in line with the timing for the general population. We would like to show you a description here but the site wont allow us.

Pin On Market Post